Sign In
Buy ORGO
$2.33
+0.0900 (+4.02%)
At Close: Jun 03, 2026
Organogenesis Holdings Inc (ORGO) Q1 2020 Earnings Call Transcript
04:30pm, Tuesday, 12'th May 2020
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO)Q1 2020 Earnings CallMay 11, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared
Organogenesis (ORGO) Reports Q1 Loss, Tops Revenue Estimates
12:25am, Tuesday, 12'th May 2020
Organogenesis (ORGO) delivered earnings and revenue surprises of -33.33% and 0.71%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results
08:05pm, Monday, 11'th May 2020
CANTON, Mass., May 11, 2020 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and.
May 11, 2020 (CDN Newswire via Comtex) --
Global Polymeric Biomateria Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 designed...
Coloplast ASB (CLPBF) CEO Kristian Villumsen on Q2 2020 Results - Earnings Call Transcript
04:42am, Monday, 11'th May 2020
Coloplast ASB (OTCPK:CLPBF) Q2 2020 Earnings Conference Call May 6, 2020 09:00 ET Company Participants Kristian Villumsen - Chief Executive Officer Anders Lonni
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Organogenesis (NASDAQ:ORGO) Rating Increased to Hold at BidaskClub
06:28am, Wednesday, 29'th Apr 2020
Organogenesis (NASDAQ:ORGO) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Wednesday, BidAskClub reports. A numbe
Goldman Sachs Group Inc. Purchases Shares of 19,131 Organogenesis Holdings Inc (NASDAQ:ORGO)
10:36am, Monday, 27'th Apr 2020
Goldman Sachs Group Inc. purchased a new stake in shares of Organogenesis Holdings Inc (NASDAQ:ORGO) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securit
Analyzing Organogenesis (NASDAQ:ORGO) & Lannett (NASDAQ:LCI)
06:14am, Friday, 24'th Apr 2020
Organogenesis (NASDAQ:ORGO) and Lannett (NYSE:LCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, di
Organogenesis (NASDAQ:ORGO) Lifted to "Sell" at BidaskClub
07:38am, Wednesday, 22'nd Apr 2020
Organogenesis (NASDAQ:ORGO) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Wednesday, BidAskClub reports. Several other equities research ana
Comparing Organogenesis (ORGO) & Its Peers
11:22am, Wednesday, 15'th Apr 2020
Organogenesis (NASDAQ: ORGO) is one of 607 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Organogenesis to similar
Organogenesis Announces Virtual Education Events for April
08:05pm, Monday, 13'th Apr 2020
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 8) * Keros Therapeutics Inc (NASDAQ: KROS) (went public
Financial Comparison: Organogenesis (ORGO) and Its Rivals
05:24am, Thursday, 09'th Apr 2020
Organogenesis (NASDAQ: ORGO) is one of 606 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Organogenesis t
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for First Quarter 2020
08:05pm, Wednesday, 08'th Apr 2020
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
